Clinical Trials Directory

Trials / Completed

CompletedNCT04615195

Effect of COVID-19 Related COntainment in ChildreN

Status
Completed
Phase
Study type
Observational
Enrollment
703 (actual)
Sponsor
University Hospital, Toulouse · Academic / Other
Sex
All
Age
8 Years – 15 Years
Healthy volunteers

Summary

The current pandemic situation (SRAS COV2) is an unprecedented event and a source of stress potentially aggravated by containment. The Child Revised Impact Event Scale (CRIES-13) was evaluated in children 8 years or older in survivors of traumatic events, flood, stay in intensive care, or war (Bosnia). In this study CRIES-13 will be used to determine the prevalence of precursor signs of post-traumatic stress in children aged 8 to 15 confined between March 17, 2020 and May 2020

Detailed description

Parents of children aged 8 to 15 will be approached from different levels / places of selection / recruitment. A clinical researcher of pediatric clinical investigation center will collect the responses. If one of the holders of parental authority and the child agree to participate, an information notice will be sent to them, then they will be contacted by telephone by a clinical research assistant to answer the questionnaire. In large families, the CRIES-13 of the holder of parental authority and of the child will be applied for each of them whose age corresponds to the inclusion criteria. The duration of the study / participant call and effective response to the questionnaire by the holder of parental authority and the child will takes a maximum of 20 minutes.

Conditions

Interventions

TypeNameDescription
OTHERcries 13 questionnaireParticipant will be contacted by telephone by a clinical research assistant to answer the CRIES 13 questionnaire. In large families, the CRIES-13 of the holder of parental authority and of the child will be applied for each of them whose age corresponds to the inclusion criteria.

Timeline

Start date
2020-06-10
Primary completion
2020-07-02
Completion
2020-09-30
First posted
2020-11-04
Last updated
2022-10-14

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04615195. Inclusion in this directory is not an endorsement.